GARRISON BRADFORD & ASSOCIATES INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 4 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GARRISON BRADFORD & ASSOCIATES INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$109,000
-59.6%
87,7000.0%0.09%
-60.5%
Q1 2017$270,000
-14.8%
87,700
+12.9%
0.24%
-18.5%
Q4 2016$317,000
-39.6%
77,700
-6.0%
0.29%
-40.9%
Q3 2016$525,000
+17.7%
82,7000.0%0.49%
+13.0%
Q2 2016$446,000
-35.5%
82,7000.0%0.44%
-45.7%
Q1 2016$692,000
+6.0%
82,7000.0%0.80%
+10.0%
Q4 2015$653,000
-7.2%
82,7000.0%0.73%
-5.8%
Q3 2015$704,000
-37.3%
82,700
-8.8%
0.78%
-29.1%
Q2 2015$1,122,000
+4.1%
90,7000.0%1.10%
+8.8%
Q1 2015$1,078,000
+5.2%
90,7000.0%1.01%
+8.4%
Q4 2014$1,025,000
+22.9%
90,700
-4.5%
0.93%
+11.4%
Q3 2014$834,000
+16.8%
95,001
-3.1%
0.83%
+25.6%
Q2 2014$714,000
+44.5%
98,0010.0%0.66%
+39.5%
Q1 2014$494,000
-5.4%
98,0010.0%0.48%
-3.4%
Q4 2013$522,000
+40.7%
98,0010.0%0.49%
+29.7%
Q3 2013$371,000
-43.9%
98,0010.0%0.38%
-46.6%
Q2 2013$661,00098,0010.71%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders